How big is Innospec, Inc.?

As of Jun 18, Innospec, Inc. has a market capitalization of 2,484.53 million, with net sales of 1,786.00 million and a net profit of 27.00 million over the latest four quarters.

Market Cap: As of Jun 18, Innospec, Inc. has a market capitalization of 2,484.53 million, categorizing it as a Small Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Innospec, Inc. reported net sales of 1,786.00 million and a net profit of 27.00 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 1,211.20 million and total assets of 1,734.70 million.

What does Innospec, Inc. do?

Innospec, Inc. is a specialty chemicals company that develops and supplies chemicals for applications like fuel additives and personal care. As of March 2025, it reported net sales of $441 million and a market cap of approximately $2.48 billion.

Overview:<BR>Innospec, Inc. is a specialty chemicals company engaged in developing, manufacturing, blending, marketing, and supplying specialty chemicals for various applications, including fuel additives and personal care, within the Chemicals & Petrochemicals industry and small-cap market.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 441 Million (Quarterly Results - Mar 2025)<BR>Most recent Net Profit: 33 Million (Quarterly Results - Mar 2025)<BR>Market-cap: USD 2,484.53 Million (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 14.00<BR>Dividend Yield: 815.68%<BR>Debt Equity: -0.23<BR>Return on Equity: 14.14%<BR>Price to Book: 1.97<BR><BR>Contact Details:<BR>Address: 8310 S Valley Hwy Ste 350, ENGLEWOOD CO: 80112-5931<BR>Tel: ['1 303 5660528', '44 151 3566241']<BR>Fax: 1 302 6555049<BR>Website: http://www.innospecinc.com/

Should I buy, sell or hold Innospec, Inc.?

Who are in the management team of Innospec, Inc.?

As of March 2022, the management team of Innospec, Inc. includes Non-Executive Chairman Milton Blackmore, CEO Patrick Williams, Directors Elizabeth Arnold, Claudia Poccia, David Landless, and Lawrence Padfield. They are responsible for the company's strategic direction and governance.

As of March 2022, the management team of Innospec, Inc. includes the following individuals:<BR><BR>- Mr. Milton Blackmore, Non-Executive Chairman<BR>- Mr. Patrick Williams, President, Chief Executive Officer, and Director<BR>- Ms. Elizabeth Arnold, Director<BR>- Ms. Claudia Poccia, Director<BR>- Mr. David Landless, Independent Director<BR>- Mr. Lawrence Padfield, Independent Director<BR><BR>These members play key roles in guiding the company's strategic direction and governance.

Is Innospec, Inc. technically bullish or bearish?

As of September 9, 2025, Innospec, Inc. has shifted to a bearish trend with moderate strength, indicated by negative daily moving averages and Bollinger Bands, while underperforming the S&P 500 with a year-to-date return of -25.41%.

As of 9 September 2025, the technical trend for Innospec, Inc. has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength, driven by bearish signals from the daily moving averages and Bollinger Bands, alongside a monthly bearish MACD and KST. The weekly indicators show mixed signals, with the MACD and KST being mildly bullish, but the overall trend remains negative. In terms of performance, Innospec has underperformed the S&P 500 across multiple periods, with a year-to-date return of -25.41% compared to the S&P 500's 12.22%.

Is Innospec, Inc. overvalued or undervalued?

As of October 24, 2025, Innospec, Inc. is fairly valued with a P/E ratio of 14 and an EV to EBITDA of 10.31, but has underperformed the S&P 500 with a year-to-date return of -30.67%.

As of 24 October 2025, the valuation grade for Innospec, Inc. has moved from attractive to fair, indicating a shift in its perceived value. Based on the current metrics, the company appears to be fairly valued. Key ratios include a P/E ratio of 14, an EV to EBITDA of 10.31, and a PEG ratio of 0.82, which suggest that the stock is reasonably priced relative to its earnings growth potential.<BR><BR>In comparison to its peers, Eastman Chemical Co. has a higher P/E ratio of 15.68, while Element Solutions, Inc. shows a significantly higher EV to EBITDA of 14.82, indicating that Innospec is competitively positioned within its industry. Notably, Innospec's stock has underperformed relative to the S&P 500, with a year-to-date return of -30.67% compared to the index's 15.47%, reinforcing the notion that the stock may be struggling to attract investor interest despite its fair valuation.